APA (7th ed.) Citation

KA, F., AS, C., A, B., PD, A., MH, C., DS, L., . . . LL, C. (2025). Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer. JCI insight, 10(20), . https://doi.org/10.1172/jci.insight.196230

Chicago Style (17th ed.) Citation

KA, Fernandez, et al. "Lower, More Frequent Cisplatin Dosing Minimizes Hearing Loss in Head and Neck Cancer." JCI Insight 10, no. 20 (2025). https://doi.org/10.1172/jci.insight.196230.

MLA (9th ed.) Citation

KA, Fernandez, et al. "Lower, More Frequent Cisplatin Dosing Minimizes Hearing Loss in Head and Neck Cancer." JCI Insight, vol. 10, no. 20, 2025, https://doi.org/10.1172/jci.insight.196230.